CIM
NUVA

Contravisory Investment Management’s NuVasive, Inc. NUVA Stock Holding History

Contravisory Investment Management’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,306
Closed -$114K – 350
2018
Q4 		$114K Buy
+2,306
New +$139K 0.05% 167
2018
Q1 		– Sell
-8
Closed – – 475
2017
Q4 		$0 Hold
8
– – ﹤0.01% 544
2017
Q3 		$0 Buy
+8
New +$529 ﹤0.01% 511

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Contravisory Investment Management's NUVA Position: Q1 2019 in Review

Contravisory Investment Management sold out of NuVasive, Inc. (NUVA) in Q1 2019, closing a stake of 2,306 shares — an estimated $114K sold.

Contravisory Investment Management first reported a position in NUVA in Q3 2017 and held it in 3 quarters. The position peaked at $114K in Q4 2018. 255 funds tracked by Wall St. Rank hold NUVA as of Q1 2019.

  • Contravisory Investment Management reported no remaining NuVasive, Inc. position as of Q1 2019 after selling out during the quarter.
  • Contravisory Investment Management sold 2,306 NuVasive, Inc. shares in Q1 2019, an estimated $114K.
  • Contravisory Investment Management first reported a position in NuVasive, Inc. in Q3 2017 and held it in 3 quarters.
  • Contravisory Investment Management's NuVasive, Inc. position peaked at $114K in Q4 2018.
  • 255 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2019.

Based on Contravisory Investment Management's 13F filing for Q1 2019, filed 8 Apr 2019.